Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,815
archived clinical trials in
Parkinsons Disease

Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
A Multi-center, Double-blind, Randomized, Parallel-Group, Placebo-Controlled Study to Assess the Clinical Effect of Droxidopa in the Treatment of Symptomatic Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
Status: Enrolling
Updated:  7/18/2012
Parker Jewish Institute For Health Care and Rehabilitation Foundation
mi
from
New Hyde Park, NY
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
A Multi-center, Double-blind, Randomized, Parallel-Group, Placebo-Controlled Study to Assess the Clinical Effect of Droxidopa in the Treatment of Symptomatic Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
Status: Enrolling
Updated: 7/18/2012
Parker Jewish Institute For Health Care and Rehabilitation Foundation
mi
from
New Hyde Park, NY
Click here to add this to my saved trials
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
A Multi-center, Double-blind, Randomized, Parallel-Group, Placebo-Controlled Study to Assess the Clinical Effect of Droxidopa in the Treatment of Symptomatic Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
Status: Enrolling
Updated:  7/18/2012
Beth Israel Med Ctr
mi
from
New York, NY
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
A Multi-center, Double-blind, Randomized, Parallel-Group, Placebo-Controlled Study to Assess the Clinical Effect of Droxidopa in the Treatment of Symptomatic Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
Status: Enrolling
Updated: 7/18/2012
Beth Israel Med Ctr
mi
from
New York, NY
Click here to add this to my saved trials
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
A Multi-center, Double-blind, Randomized, Parallel-Group, Placebo-Controlled Study to Assess the Clinical Effect of Droxidopa in the Treatment of Symptomatic Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
Status: Enrolling
Updated:  7/18/2012
New York University
mi
from
New York, NY
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
A Multi-center, Double-blind, Randomized, Parallel-Group, Placebo-Controlled Study to Assess the Clinical Effect of Droxidopa in the Treatment of Symptomatic Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
Status: Enrolling
Updated: 7/18/2012
New York University
mi
from
New York, NY
Click here to add this to my saved trials
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
A Multi-center, Double-blind, Randomized, Parallel-Group, Placebo-Controlled Study to Assess the Clinical Effect of Droxidopa in the Treatment of Symptomatic Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
Status: Enrolling
Updated:  7/18/2012
Neurological Care of CNY
mi
from
Liverpool, NY
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
A Multi-center, Double-blind, Randomized, Parallel-Group, Placebo-Controlled Study to Assess the Clinical Effect of Droxidopa in the Treatment of Symptomatic Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
Status: Enrolling
Updated: 7/18/2012
Neurological Care of CNY
mi
from
Liverpool, NY
Click here to add this to my saved trials
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
A Multi-center, Double-blind, Randomized, Parallel-Group, Placebo-Controlled Study to Assess the Clinical Effect of Droxidopa in the Treatment of Symptomatic Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
Status: Enrolling
Updated:  7/18/2012
Asheville Neurology Specialists, PA
mi
from
Asheville, NC
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
A Multi-center, Double-blind, Randomized, Parallel-Group, Placebo-Controlled Study to Assess the Clinical Effect of Droxidopa in the Treatment of Symptomatic Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
Status: Enrolling
Updated: 7/18/2012
Asheville Neurology Specialists, PA
mi
from
Asheville, NC
Click here to add this to my saved trials
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
A Multi-center, Double-blind, Randomized, Parallel-Group, Placebo-Controlled Study to Assess the Clinical Effect of Droxidopa in the Treatment of Symptomatic Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
Status: Enrolling
Updated:  7/18/2012
Kernodle Clinic, Inc.
mi
from
Burlington, NC
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
A Multi-center, Double-blind, Randomized, Parallel-Group, Placebo-Controlled Study to Assess the Clinical Effect of Droxidopa in the Treatment of Symptomatic Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
Status: Enrolling
Updated: 7/18/2012
Kernodle Clinic, Inc.
mi
from
Burlington, NC
Click here to add this to my saved trials
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
A Multi-center, Double-blind, Randomized, Parallel-Group, Placebo-Controlled Study to Assess the Clinical Effect of Droxidopa in the Treatment of Symptomatic Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
Status: Enrolling
Updated:  7/18/2012
Guilford Neurologic Associates
mi
from
Winston-Salem, NC
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
A Multi-center, Double-blind, Randomized, Parallel-Group, Placebo-Controlled Study to Assess the Clinical Effect of Droxidopa in the Treatment of Symptomatic Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
Status: Enrolling
Updated: 7/18/2012
Guilford Neurologic Associates
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
A Multi-center, Double-blind, Randomized, Parallel-Group, Placebo-Controlled Study to Assess the Clinical Effect of Droxidopa in the Treatment of Symptomatic Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
Status: Enrolling
Updated:  7/18/2012
Clinical Trials of America Inc
mi
from
Hickory, NC
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
A Multi-center, Double-blind, Randomized, Parallel-Group, Placebo-Controlled Study to Assess the Clinical Effect of Droxidopa in the Treatment of Symptomatic Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
Status: Enrolling
Updated: 7/18/2012
Clinical Trials of America Inc
mi
from
Hickory, NC
Click here to add this to my saved trials
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
A Multi-center, Double-blind, Randomized, Parallel-Group, Placebo-Controlled Study to Assess the Clinical Effect of Droxidopa in the Treatment of Symptomatic Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
Status: Enrolling
Updated:  7/18/2012
Central Carolina Neurology And Sleep, PA
mi
from
Salisbury, NC
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
A Multi-center, Double-blind, Randomized, Parallel-Group, Placebo-Controlled Study to Assess the Clinical Effect of Droxidopa in the Treatment of Symptomatic Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
Status: Enrolling
Updated: 7/18/2012
Central Carolina Neurology And Sleep, PA
mi
from
Salisbury, NC
Click here to add this to my saved trials
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
A Multi-center, Double-blind, Randomized, Parallel-Group, Placebo-Controlled Study to Assess the Clinical Effect of Droxidopa in the Treatment of Symptomatic Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
Status: Enrolling
Updated:  7/18/2012
Ohio Clinical Research
mi
from
Canton, OH
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
A Multi-center, Double-blind, Randomized, Parallel-Group, Placebo-Controlled Study to Assess the Clinical Effect of Droxidopa in the Treatment of Symptomatic Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
Status: Enrolling
Updated: 7/18/2012
Ohio Clinical Research
mi
from
Canton, OH
Click here to add this to my saved trials
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
A Multi-center, Double-blind, Randomized, Parallel-Group, Placebo-Controlled Study to Assess the Clinical Effect of Droxidopa in the Treatment of Symptomatic Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
Status: Enrolling
Updated:  7/18/2012
Community Research
mi
from
Cincinnati, OH
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
A Multi-center, Double-blind, Randomized, Parallel-Group, Placebo-Controlled Study to Assess the Clinical Effect of Droxidopa in the Treatment of Symptomatic Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
Status: Enrolling
Updated: 7/18/2012
Community Research
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
A Multi-center, Double-blind, Randomized, Parallel-Group, Placebo-Controlled Study to Assess the Clinical Effect of Droxidopa in the Treatment of Symptomatic Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
Status: Enrolling
Updated:  7/18/2012
The Ohio State University, Wexner Medical Center
mi
from
Columbus, OH
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
A Multi-center, Double-blind, Randomized, Parallel-Group, Placebo-Controlled Study to Assess the Clinical Effect of Droxidopa in the Treatment of Symptomatic Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
Status: Enrolling
Updated: 7/18/2012
The Ohio State University, Wexner Medical Center
mi
from
Columbus, OH
Click here to add this to my saved trials
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
A Multi-center, Double-blind, Randomized, Parallel-Group, Placebo-Controlled Study to Assess the Clinical Effect of Droxidopa in the Treatment of Symptomatic Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
Status: Enrolling
Updated:  7/18/2012
University of Toledo
mi
from
Toledo, OH
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
A Multi-center, Double-blind, Randomized, Parallel-Group, Placebo-Controlled Study to Assess the Clinical Effect of Droxidopa in the Treatment of Symptomatic Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
Status: Enrolling
Updated: 7/18/2012
University of Toledo
mi
from
Toledo, OH
Click here to add this to my saved trials
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
A Multi-center, Double-blind, Randomized, Parallel-Group, Placebo-Controlled Study to Assess the Clinical Effect of Droxidopa in the Treatment of Symptomatic Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
Status: Enrolling
Updated:  7/18/2012
Red River Medical Research Center
mi
from
Oklahoma City, OK
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
A Multi-center, Double-blind, Randomized, Parallel-Group, Placebo-Controlled Study to Assess the Clinical Effect of Droxidopa in the Treatment of Symptomatic Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
Status: Enrolling
Updated: 7/18/2012
Red River Medical Research Center
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
A Multi-center, Double-blind, Randomized, Parallel-Group, Placebo-Controlled Study to Assess the Clinical Effect of Droxidopa in the Treatment of Symptomatic Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
Status: Enrolling
Updated:  7/18/2012
The Movement Disorder Clinic of Oklahoma
mi
from
Tulsa, OK
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
A Multi-center, Double-blind, Randomized, Parallel-Group, Placebo-Controlled Study to Assess the Clinical Effect of Droxidopa in the Treatment of Symptomatic Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
Status: Enrolling
Updated: 7/18/2012
The Movement Disorder Clinic of Oklahoma
mi
from
Tulsa, OK
Click here to add this to my saved trials
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
A Multi-center, Double-blind, Randomized, Parallel-Group, Placebo-Controlled Study to Assess the Clinical Effect of Droxidopa in the Treatment of Symptomatic Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
Status: Enrolling
Updated:  7/18/2012
Ilumina Clinical Associates
mi
from
Uniontown, PA
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
A Multi-center, Double-blind, Randomized, Parallel-Group, Placebo-Controlled Study to Assess the Clinical Effect of Droxidopa in the Treatment of Symptomatic Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
Status: Enrolling
Updated: 7/18/2012
Ilumina Clinical Associates
mi
from
Uniontown, PA
Click here to add this to my saved trials
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
A Multi-center, Double-blind, Randomized, Parallel-Group, Placebo-Controlled Study to Assess the Clinical Effect of Droxidopa in the Treatment of Symptomatic Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
Status: Enrolling
Updated:  7/18/2012
Clinical Trials Research Services, LLC
mi
from
Pittsburgh, PA
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
A Multi-center, Double-blind, Randomized, Parallel-Group, Placebo-Controlled Study to Assess the Clinical Effect of Droxidopa in the Treatment of Symptomatic Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
Status: Enrolling
Updated: 7/18/2012
Clinical Trials Research Services, LLC
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
A Multi-center, Double-blind, Randomized, Parallel-Group, Placebo-Controlled Study to Assess the Clinical Effect of Droxidopa in the Treatment of Symptomatic Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
Status: Enrolling
Updated:  7/18/2012
Research Protocol Management Specialists
mi
from
Pittsburg, PA
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
A Multi-center, Double-blind, Randomized, Parallel-Group, Placebo-Controlled Study to Assess the Clinical Effect of Droxidopa in the Treatment of Symptomatic Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
Status: Enrolling
Updated: 7/18/2012
Research Protocol Management Specialists
mi
from
Pittsburg, PA
Click here to add this to my saved trials
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
A Multi-center, Double-blind, Randomized, Parallel-Group, Placebo-Controlled Study to Assess the Clinical Effect of Droxidopa in the Treatment of Symptomatic Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
Status: Enrolling
Updated:  7/18/2012
UT Southwestern Medical Center at Dallas
mi
from
Dallas, TX
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
A Multi-center, Double-blind, Randomized, Parallel-Group, Placebo-Controlled Study to Assess the Clinical Effect of Droxidopa in the Treatment of Symptomatic Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
Status: Enrolling
Updated: 7/18/2012
UT Southwestern Medical Center at Dallas
mi
from
Dallas, TX
Click here to add this to my saved trials
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
A Multi-center, Double-blind, Randomized, Parallel-Group, Placebo-Controlled Study to Assess the Clinical Effect of Droxidopa in the Treatment of Symptomatic Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
Status: Enrolling
Updated:  7/18/2012
Baylor College of Medicine
mi
from
Houston, TX
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
A Multi-center, Double-blind, Randomized, Parallel-Group, Placebo-Controlled Study to Assess the Clinical Effect of Droxidopa in the Treatment of Symptomatic Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
Status: Enrolling
Updated: 7/18/2012
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
A Multi-center, Double-blind, Randomized, Parallel-Group, Placebo-Controlled Study to Assess the Clinical Effect of Droxidopa in the Treatment of Symptomatic Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
Status: Enrolling
Updated:  7/18/2012
Todd Swick, MD, PA
mi
from
Houston, TX
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
A Multi-center, Double-blind, Randomized, Parallel-Group, Placebo-Controlled Study to Assess the Clinical Effect of Droxidopa in the Treatment of Symptomatic Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
Status: Enrolling
Updated: 7/18/2012
Todd Swick, MD, PA
mi
from
Houston, TX
Click here to add this to my saved trials
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
A Multi-center, Double-blind, Randomized, Parallel-Group, Placebo-Controlled Study to Assess the Clinical Effect of Droxidopa in the Treatment of Symptomatic Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
Status: Enrolling
Updated:  7/18/2012
JM Neuroscience Research
mi
from
Salt Lake City, UT
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
A Multi-center, Double-blind, Randomized, Parallel-Group, Placebo-Controlled Study to Assess the Clinical Effect of Droxidopa in the Treatment of Symptomatic Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
Status: Enrolling
Updated: 7/18/2012
JM Neuroscience Research
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
A Multi-center, Double-blind, Randomized, Parallel-Group, Placebo-Controlled Study to Assess the Clinical Effect of Droxidopa in the Treatment of Symptomatic Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
Status: Enrolling
Updated:  7/18/2012
Neurological Associates, Inc.
mi
from
Richmond, VA
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
A Multi-center, Double-blind, Randomized, Parallel-Group, Placebo-Controlled Study to Assess the Clinical Effect of Droxidopa in the Treatment of Symptomatic Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
Status: Enrolling
Updated: 7/18/2012
Neurological Associates, Inc.
mi
from
Richmond, VA
Click here to add this to my saved trials
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
A Multi-center, Double-blind, Randomized, Parallel-Group, Placebo-Controlled Study to Assess the Clinical Effect of Droxidopa in the Treatment of Symptomatic Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
Status: Enrolling
Updated:  7/18/2012
Sentara Neurology Specialists
mi
from
Virginia Beach, VA
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
A Multi-center, Double-blind, Randomized, Parallel-Group, Placebo-Controlled Study to Assess the Clinical Effect of Droxidopa in the Treatment of Symptomatic Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
Status: Enrolling
Updated: 7/18/2012
Sentara Neurology Specialists
mi
from
Virginia Beach, VA
Click here to add this to my saved trials
Increased Gut Permeability to Lipopolysaccharides (LPS) in Parkinson's Disease
Increased Gut Permeability to Lipopolysaccharides (LPS) in Parkinson's Disease
Status: Enrolling
Updated:  7/24/2012
Rush University Medical Center
mi
from
Chicago, IL
Increased Gut Permeability to Lipopolysaccharides (LPS) in Parkinson's Disease
Increased Gut Permeability to Lipopolysaccharides (LPS) in Parkinson's Disease
Status: Enrolling
Updated: 7/24/2012
Rush University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Pharmacokinetics of BIA 9-1067 in Healthy Japanese and Caucasian Subjects
Randomized, Double-Blinded, Placebo-Controlled, Multiple Ascending Dose Study to Compare the Pharmacokinetics of BIA 9-1067 in Healthy Japanese and Caucasian Subjects
Status: Enrolling
Updated:  8/21/2012
Covance Clinical Research Unit, Inc.
mi
from
Honolulu, HI
Pharmacokinetics of BIA 9-1067 in Healthy Japanese and Caucasian Subjects
Randomized, Double-Blinded, Placebo-Controlled, Multiple Ascending Dose Study to Compare the Pharmacokinetics of BIA 9-1067 in Healthy Japanese and Caucasian Subjects
Status: Enrolling
Updated: 8/21/2012
Covance Clinical Research Unit, Inc.
mi
from
Honolulu, HI
Click here to add this to my saved trials
An Active-Controlled Extension Study to P04938 and P07037 (P06153 AM3)
A Phase 3, 40-Week, Active-Controlled, Double-Blind, Double-Dummy Extension Study of Preladenant in Subjects With Moderate to Severe Parkinson's Disease (Phase 3, Protocol No. P06153)
Status: Enrolling
Updated:  9/21/2012
Clinical Research Facility
mi
from
Gilbert, AZ
An Active-Controlled Extension Study to P04938 and P07037 (P06153 AM3)
A Phase 3, 40-Week, Active-Controlled, Double-Blind, Double-Dummy Extension Study of Preladenant in Subjects With Moderate to Severe Parkinson's Disease (Phase 3, Protocol No. P06153)
Status: Enrolling
Updated: 9/21/2012
Clinical Research Facility
mi
from
Gilbert, AZ
Click here to add this to my saved trials
An Active-Controlled Extension Study to P04938 and P07037 (P06153 AM3)
A Phase 3, 40-Week, Active-Controlled, Double-Blind, Double-Dummy Extension Study of Preladenant in Subjects With Moderate to Severe Parkinson's Disease (Phase 3, Protocol No. P06153)
Status: Enrolling
Updated:  9/21/2012
Clinical Research Facility
mi
from
Phoenix, AZ
An Active-Controlled Extension Study to P04938 and P07037 (P06153 AM3)
A Phase 3, 40-Week, Active-Controlled, Double-Blind, Double-Dummy Extension Study of Preladenant in Subjects With Moderate to Severe Parkinson's Disease (Phase 3, Protocol No. P06153)
Status: Enrolling
Updated: 9/21/2012
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
An Active-Controlled Extension Study to P04938 and P07037 (P06153 AM3)
A Phase 3, 40-Week, Active-Controlled, Double-Blind, Double-Dummy Extension Study of Preladenant in Subjects With Moderate to Severe Parkinson's Disease (Phase 3, Protocol No. P06153)
Status: Enrolling
Updated:  9/21/2012
Clinical Research Facility
mi
from
Sun City, AZ
An Active-Controlled Extension Study to P04938 and P07037 (P06153 AM3)
A Phase 3, 40-Week, Active-Controlled, Double-Blind, Double-Dummy Extension Study of Preladenant in Subjects With Moderate to Severe Parkinson's Disease (Phase 3, Protocol No. P06153)
Status: Enrolling
Updated: 9/21/2012
Clinical Research Facility
mi
from
Sun City, AZ
Click here to add this to my saved trials
An Active-Controlled Extension Study to P04938 and P07037 (P06153 AM3)
A Phase 3, 40-Week, Active-Controlled, Double-Blind, Double-Dummy Extension Study of Preladenant in Subjects With Moderate to Severe Parkinson's Disease (Phase 3, Protocol No. P06153)
Status: Enrolling
Updated:  9/21/2012
Clinical Research Facility
mi
from
Tucson, AZ
An Active-Controlled Extension Study to P04938 and P07037 (P06153 AM3)
A Phase 3, 40-Week, Active-Controlled, Double-Blind, Double-Dummy Extension Study of Preladenant in Subjects With Moderate to Severe Parkinson's Disease (Phase 3, Protocol No. P06153)
Status: Enrolling
Updated: 9/21/2012
Clinical Research Facility
mi
from
Tucson, AZ
Click here to add this to my saved trials
An Active-Controlled Extension Study to P04938 and P07037 (P06153 AM3)
A Phase 3, 40-Week, Active-Controlled, Double-Blind, Double-Dummy Extension Study of Preladenant in Subjects With Moderate to Severe Parkinson's Disease (Phase 3, Protocol No. P06153)
Status: Enrolling
Updated:  9/21/2012
Clinical Research Facility
mi
from
Tucson, AZ
An Active-Controlled Extension Study to P04938 and P07037 (P06153 AM3)
A Phase 3, 40-Week, Active-Controlled, Double-Blind, Double-Dummy Extension Study of Preladenant in Subjects With Moderate to Severe Parkinson's Disease (Phase 3, Protocol No. P06153)
Status: Enrolling
Updated: 9/21/2012
Clinical Research Facility
mi
from
Tucson, AZ
Click here to add this to my saved trials
An Active-Controlled Extension Study to P04938 and P07037 (P06153 AM3)
A Phase 3, 40-Week, Active-Controlled, Double-Blind, Double-Dummy Extension Study of Preladenant in Subjects With Moderate to Severe Parkinson's Disease (Phase 3, Protocol No. P06153)
Status: Enrolling
Updated:  9/21/2012
Clinical Research Facility
mi
from
Little Rock, AR
An Active-Controlled Extension Study to P04938 and P07037 (P06153 AM3)
A Phase 3, 40-Week, Active-Controlled, Double-Blind, Double-Dummy Extension Study of Preladenant in Subjects With Moderate to Severe Parkinson's Disease (Phase 3, Protocol No. P06153)
Status: Enrolling
Updated: 9/21/2012
Clinical Research Facility
mi
from
Little Rock, AR
Click here to add this to my saved trials
An Active-Controlled Extension Study to P04938 and P07037 (P06153 AM3)
A Phase 3, 40-Week, Active-Controlled, Double-Blind, Double-Dummy Extension Study of Preladenant in Subjects With Moderate to Severe Parkinson's Disease (Phase 3, Protocol No. P06153)
Status: Enrolling
Updated:  9/21/2012
Clinical Research Facility
mi
from
Fresno, CA
An Active-Controlled Extension Study to P04938 and P07037 (P06153 AM3)
A Phase 3, 40-Week, Active-Controlled, Double-Blind, Double-Dummy Extension Study of Preladenant in Subjects With Moderate to Severe Parkinson's Disease (Phase 3, Protocol No. P06153)
Status: Enrolling
Updated: 9/21/2012
Clinical Research Facility
mi
from
Fresno, CA
Click here to add this to my saved trials
An Active-Controlled Extension Study to P04938 and P07037 (P06153 AM3)
A Phase 3, 40-Week, Active-Controlled, Double-Blind, Double-Dummy Extension Study of Preladenant in Subjects With Moderate to Severe Parkinson's Disease (Phase 3, Protocol No. P06153)
Status: Enrolling
Updated:  9/21/2012
Clinical Research Facility
mi
from
Long Beach, CA
An Active-Controlled Extension Study to P04938 and P07037 (P06153 AM3)
A Phase 3, 40-Week, Active-Controlled, Double-Blind, Double-Dummy Extension Study of Preladenant in Subjects With Moderate to Severe Parkinson's Disease (Phase 3, Protocol No. P06153)
Status: Enrolling
Updated: 9/21/2012
Clinical Research Facility
mi
from
Long Beach, CA
Click here to add this to my saved trials
An Active-Controlled Extension Study to P04938 and P07037 (P06153 AM3)
A Phase 3, 40-Week, Active-Controlled, Double-Blind, Double-Dummy Extension Study of Preladenant in Subjects With Moderate to Severe Parkinson's Disease (Phase 3, Protocol No. P06153)
Status: Enrolling
Updated:  9/21/2012
Clinical Research Facility
mi
from
Oxnard, CA
An Active-Controlled Extension Study to P04938 and P07037 (P06153 AM3)
A Phase 3, 40-Week, Active-Controlled, Double-Blind, Double-Dummy Extension Study of Preladenant in Subjects With Moderate to Severe Parkinson's Disease (Phase 3, Protocol No. P06153)
Status: Enrolling
Updated: 9/21/2012
Clinical Research Facility
mi
from
Oxnard, CA
Click here to add this to my saved trials
An Active-Controlled Extension Study to P04938 and P07037 (P06153 AM3)
A Phase 3, 40-Week, Active-Controlled, Double-Blind, Double-Dummy Extension Study of Preladenant in Subjects With Moderate to Severe Parkinson's Disease (Phase 3, Protocol No. P06153)
Status: Enrolling
Updated:  9/21/2012
Clinical Research Facility
mi
from
Reseda, CA
An Active-Controlled Extension Study to P04938 and P07037 (P06153 AM3)
A Phase 3, 40-Week, Active-Controlled, Double-Blind, Double-Dummy Extension Study of Preladenant in Subjects With Moderate to Severe Parkinson's Disease (Phase 3, Protocol No. P06153)
Status: Enrolling
Updated: 9/21/2012
Clinical Research Facility
mi
from
Reseda, CA
Click here to add this to my saved trials
An Active-Controlled Extension Study to P04938 and P07037 (P06153 AM3)
A Phase 3, 40-Week, Active-Controlled, Double-Blind, Double-Dummy Extension Study of Preladenant in Subjects With Moderate to Severe Parkinson's Disease (Phase 3, Protocol No. P06153)
Status: Enrolling
Updated:  9/21/2012
Clinical Research Facility
mi
from
Santa Rosa, CA
An Active-Controlled Extension Study to P04938 and P07037 (P06153 AM3)
A Phase 3, 40-Week, Active-Controlled, Double-Blind, Double-Dummy Extension Study of Preladenant in Subjects With Moderate to Severe Parkinson's Disease (Phase 3, Protocol No. P06153)
Status: Enrolling
Updated: 9/21/2012
Clinical Research Facility
mi
from
Santa Rosa, CA
Click here to add this to my saved trials
An Active-Controlled Extension Study to P04938 and P07037 (P06153 AM3)
A Phase 3, 40-Week, Active-Controlled, Double-Blind, Double-Dummy Extension Study of Preladenant in Subjects With Moderate to Severe Parkinson's Disease (Phase 3, Protocol No. P06153)
Status: Enrolling
Updated:  9/21/2012
Clinical Research Facility
mi
from
Boulder, CO
An Active-Controlled Extension Study to P04938 and P07037 (P06153 AM3)
A Phase 3, 40-Week, Active-Controlled, Double-Blind, Double-Dummy Extension Study of Preladenant in Subjects With Moderate to Severe Parkinson's Disease (Phase 3, Protocol No. P06153)
Status: Enrolling
Updated: 9/21/2012
Clinical Research Facility
mi
from
Boulder, CO
Click here to add this to my saved trials
An Active-Controlled Extension Study to P04938 and P07037 (P06153 AM3)
A Phase 3, 40-Week, Active-Controlled, Double-Blind, Double-Dummy Extension Study of Preladenant in Subjects With Moderate to Severe Parkinson's Disease (Phase 3, Protocol No. P06153)
Status: Enrolling
Updated:  9/21/2012
Clinical Research Facility
mi
from
Englewood, CO
An Active-Controlled Extension Study to P04938 and P07037 (P06153 AM3)
A Phase 3, 40-Week, Active-Controlled, Double-Blind, Double-Dummy Extension Study of Preladenant in Subjects With Moderate to Severe Parkinson's Disease (Phase 3, Protocol No. P06153)
Status: Enrolling
Updated: 9/21/2012
Clinical Research Facility
mi
from
Englewood, CO
Click here to add this to my saved trials
An Active-Controlled Extension Study to P04938 and P07037 (P06153 AM3)
A Phase 3, 40-Week, Active-Controlled, Double-Blind, Double-Dummy Extension Study of Preladenant in Subjects With Moderate to Severe Parkinson's Disease (Phase 3, Protocol No. P06153)
Status: Enrolling
Updated:  9/21/2012
Clinical Research Facility
mi
from
Atlantis, FL
An Active-Controlled Extension Study to P04938 and P07037 (P06153 AM3)
A Phase 3, 40-Week, Active-Controlled, Double-Blind, Double-Dummy Extension Study of Preladenant in Subjects With Moderate to Severe Parkinson's Disease (Phase 3, Protocol No. P06153)
Status: Enrolling
Updated: 9/21/2012
Clinical Research Facility
mi
from
Atlantis, FL
Click here to add this to my saved trials
An Active-Controlled Extension Study to P04938 and P07037 (P06153 AM3)
A Phase 3, 40-Week, Active-Controlled, Double-Blind, Double-Dummy Extension Study of Preladenant in Subjects With Moderate to Severe Parkinson's Disease (Phase 3, Protocol No. P06153)
Status: Enrolling
Updated:  9/21/2012
Clinical Research Facility
mi
from
Boca Raton, FL
An Active-Controlled Extension Study to P04938 and P07037 (P06153 AM3)
A Phase 3, 40-Week, Active-Controlled, Double-Blind, Double-Dummy Extension Study of Preladenant in Subjects With Moderate to Severe Parkinson's Disease (Phase 3, Protocol No. P06153)
Status: Enrolling
Updated: 9/21/2012
Clinical Research Facility
mi
from
Boca Raton, FL
Click here to add this to my saved trials
An Active-Controlled Extension Study to P04938 and P07037 (P06153 AM3)
A Phase 3, 40-Week, Active-Controlled, Double-Blind, Double-Dummy Extension Study of Preladenant in Subjects With Moderate to Severe Parkinson's Disease (Phase 3, Protocol No. P06153)
Status: Enrolling
Updated:  9/21/2012
Clinical Research Facility
mi
from
Bradenton, FL
An Active-Controlled Extension Study to P04938 and P07037 (P06153 AM3)
A Phase 3, 40-Week, Active-Controlled, Double-Blind, Double-Dummy Extension Study of Preladenant in Subjects With Moderate to Severe Parkinson's Disease (Phase 3, Protocol No. P06153)
Status: Enrolling
Updated: 9/21/2012
Clinical Research Facility
mi
from
Bradenton, FL
Click here to add this to my saved trials
An Active-Controlled Extension Study to P04938 and P07037 (P06153 AM3)
A Phase 3, 40-Week, Active-Controlled, Double-Blind, Double-Dummy Extension Study of Preladenant in Subjects With Moderate to Severe Parkinson's Disease (Phase 3, Protocol No. P06153)
Status: Enrolling
Updated:  9/21/2012
Clinical Research Facility
mi
from
Hollywood, FL
An Active-Controlled Extension Study to P04938 and P07037 (P06153 AM3)
A Phase 3, 40-Week, Active-Controlled, Double-Blind, Double-Dummy Extension Study of Preladenant in Subjects With Moderate to Severe Parkinson's Disease (Phase 3, Protocol No. P06153)
Status: Enrolling
Updated: 9/21/2012
Clinical Research Facility
mi
from
Hollywood, FL
Click here to add this to my saved trials
An Active-Controlled Extension Study to P04938 and P07037 (P06153 AM3)
A Phase 3, 40-Week, Active-Controlled, Double-Blind, Double-Dummy Extension Study of Preladenant in Subjects With Moderate to Severe Parkinson's Disease (Phase 3, Protocol No. P06153)
Status: Enrolling
Updated:  9/21/2012
Clinical Research Facility
mi
from
Naples, FL
An Active-Controlled Extension Study to P04938 and P07037 (P06153 AM3)
A Phase 3, 40-Week, Active-Controlled, Double-Blind, Double-Dummy Extension Study of Preladenant in Subjects With Moderate to Severe Parkinson's Disease (Phase 3, Protocol No. P06153)
Status: Enrolling
Updated: 9/21/2012
Clinical Research Facility
mi
from
Naples, FL
Click here to add this to my saved trials
An Active-Controlled Extension Study to P04938 and P07037 (P06153 AM3)
A Phase 3, 40-Week, Active-Controlled, Double-Blind, Double-Dummy Extension Study of Preladenant in Subjects With Moderate to Severe Parkinson's Disease (Phase 3, Protocol No. P06153)
Status: Enrolling
Updated:  9/21/2012
Clinical Research Facility
mi
from
Orlando, FL
An Active-Controlled Extension Study to P04938 and P07037 (P06153 AM3)
A Phase 3, 40-Week, Active-Controlled, Double-Blind, Double-Dummy Extension Study of Preladenant in Subjects With Moderate to Severe Parkinson's Disease (Phase 3, Protocol No. P06153)
Status: Enrolling
Updated: 9/21/2012
Clinical Research Facility
mi
from
Orlando, FL
Click here to add this to my saved trials
An Active-Controlled Extension Study to P04938 and P07037 (P06153 AM3)
A Phase 3, 40-Week, Active-Controlled, Double-Blind, Double-Dummy Extension Study of Preladenant in Subjects With Moderate to Severe Parkinson's Disease (Phase 3, Protocol No. P06153)
Status: Enrolling
Updated:  9/21/2012
Clinical Research Facility
mi
from
Palm Beach Gardens, FL
An Active-Controlled Extension Study to P04938 and P07037 (P06153 AM3)
A Phase 3, 40-Week, Active-Controlled, Double-Blind, Double-Dummy Extension Study of Preladenant in Subjects With Moderate to Severe Parkinson's Disease (Phase 3, Protocol No. P06153)
Status: Enrolling
Updated: 9/21/2012
Clinical Research Facility
mi
from
Palm Beach Gardens, FL
Click here to add this to my saved trials
An Active-Controlled Extension Study to P04938 and P07037 (P06153 AM3)
A Phase 3, 40-Week, Active-Controlled, Double-Blind, Double-Dummy Extension Study of Preladenant in Subjects With Moderate to Severe Parkinson's Disease (Phase 3, Protocol No. P06153)
Status: Enrolling
Updated:  9/21/2012
Clinical Research Facility
mi
from
Tamarac, FL
An Active-Controlled Extension Study to P04938 and P07037 (P06153 AM3)
A Phase 3, 40-Week, Active-Controlled, Double-Blind, Double-Dummy Extension Study of Preladenant in Subjects With Moderate to Severe Parkinson's Disease (Phase 3, Protocol No. P06153)
Status: Enrolling
Updated: 9/21/2012
Clinical Research Facility
mi
from
Tamarac, FL
Click here to add this to my saved trials
An Active-Controlled Extension Study to P04938 and P07037 (P06153 AM3)
A Phase 3, 40-Week, Active-Controlled, Double-Blind, Double-Dummy Extension Study of Preladenant in Subjects With Moderate to Severe Parkinson's Disease (Phase 3, Protocol No. P06153)
Status: Enrolling
Updated:  9/21/2012
Clinical Research Facility
mi
from
Sunrise, FL
An Active-Controlled Extension Study to P04938 and P07037 (P06153 AM3)
A Phase 3, 40-Week, Active-Controlled, Double-Blind, Double-Dummy Extension Study of Preladenant in Subjects With Moderate to Severe Parkinson's Disease (Phase 3, Protocol No. P06153)
Status: Enrolling
Updated: 9/21/2012
Clinical Research Facility
mi
from
Sunrise, FL
Click here to add this to my saved trials
An Active-Controlled Extension Study to P04938 and P07037 (P06153 AM3)
A Phase 3, 40-Week, Active-Controlled, Double-Blind, Double-Dummy Extension Study of Preladenant in Subjects With Moderate to Severe Parkinson's Disease (Phase 3, Protocol No. P06153)
Status: Enrolling
Updated:  9/21/2012
Clinical Research Facility
mi
from
Atlanta, GA
An Active-Controlled Extension Study to P04938 and P07037 (P06153 AM3)
A Phase 3, 40-Week, Active-Controlled, Double-Blind, Double-Dummy Extension Study of Preladenant in Subjects With Moderate to Severe Parkinson's Disease (Phase 3, Protocol No. P06153)
Status: Enrolling
Updated: 9/21/2012
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
An Active-Controlled Extension Study to P04938 and P07037 (P06153 AM3)
A Phase 3, 40-Week, Active-Controlled, Double-Blind, Double-Dummy Extension Study of Preladenant in Subjects With Moderate to Severe Parkinson's Disease (Phase 3, Protocol No. P06153)
Status: Enrolling
Updated:  9/21/2012
Clinical Research Facility
mi
from
Decatur, GA
An Active-Controlled Extension Study to P04938 and P07037 (P06153 AM3)
A Phase 3, 40-Week, Active-Controlled, Double-Blind, Double-Dummy Extension Study of Preladenant in Subjects With Moderate to Severe Parkinson's Disease (Phase 3, Protocol No. P06153)
Status: Enrolling
Updated: 9/21/2012
Clinical Research Facility
mi
from
Decatur, GA
Click here to add this to my saved trials